![Corleen Roche](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 259 421 $ al 31/07/2026
Corleen M.
Roche is currently Chief Financial Officer at Iovance Biotherapeutics, Inc. since 2025.
Formerly, Ms. Roche was Secretary, Chief Financial & Accounting Officer at CG Oncology, Inc. from 2024 to 2025; Chief Financial & Accounting Officer at Immunome, Inc. from 2021 to 2024; Chief Financial Officer at Biogen, Inc. from 2019 to 2021; Chief Financial Officer at Sandoz, Inc. from 2015 to 2019.
Ms. Roche also held Chief Financial Officer roles at Iogenetics LLC, CSL Behring LLC, Wyeth Pharmaceuticals, Inc., and Pfizer Inc. Ms. Roche completed undergraduate education at Villanova University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 01/03/2026 | 2.000 ( 0 % ) | 142 380 $ | 31/07/2026 | |
| 06/08/2026 | 28.757 ( 0,01 % ) | 117 041 $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. | Director Financiero/CFO | 06/08/2025 |
| Empresas | Cargo | Fin |
|---|---|---|
| CG ONCOLOGY, INC. | Director Financiero/CFO | 05/08/2025 |
| IMMUNOME, INC. | Director Financiero/CFO | 02/01/2024 |
| BIOGEN INC. | Director Financiero/CFO | 01/04/2021 |
Sandoz, Inc.
 Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes generic pharmaceutical products | Director Financiero/CFO | 01/01/2019 |
CSL Behring LLC
 CSL Behring LLC BiotechnologyHealth Technology Manufactures and markets plasma protein products | Director Financiero/CFO | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 10 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Sandoz, Inc.
Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes generic pharmaceutical products | Health Technology |
Immunome, Inc.
 Immunome, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which discovers, develops and commercializes antibody therapeutics | Health Technology |
Iogenetics LLC
 Iogenetics LLC Miscellaneous Commercial ServicesCommercial Services Develops proprietary antimicrobial proteins and immunogenetics solutions | Commercial Services |
Villanova University
 Villanova University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology Manufactures and markets plasma protein products | Health Technology |
Iovance Biotherapeutics, Inc.
 Iovance Biotherapeutics, Inc. BiotechnologyHealth Technology Develops biotechnological products for the treatment of cancer | Health Technology |
CG Oncology, Inc.
 CG Oncology, Inc. BiotechnologyHealth Technology Operates as a late-stage clinical biopharmaceutical company focused on developing and commercializing backbone bladder-sparing therapeutic | Health Technology |
Wyeth Pharmaceuticals, Inc.
 Wyeth Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
